Earlier this year, RSB Spine reported a 97 percent sales increase for fiscal year 2010 compared to FY 2009. Its continued sales growth can be attributed to its InterPlate platform, which is a load-bearing spinal implant that allows 1.8 mm of graft loading without stress shielding. The product allows surgeons to select the flush-fit interbody construct they want and to determine how that construct will behave, according to the release.
Read the company news release about RSB Spine’s Q1 financial results.
Read other coverage about device company financial results:
– SANUWAVE Health Reports FY 2010 Revenues of $728K, 10.1% Increase
– BioMimetic Therapeutics Posts Flat 4Q Revenue at $400K
– Orthovita Reports 4Q Revenues of $23.4M, 4% Decrease
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
